Market News / Story
Simulations Plus Announces Completion of Acquisition by Altaris
BusinessWire ·
BusinessWire reports: Simulations Plus, Inc. ( ) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the completion of its acquisition by affiliates of Altaris, LLC ("Altaris"), an investment firm focused exclusively on the healthcare industry. The transaction was originally announced on June 16, 2026. At the effective time of the merger each Simulations Plus shareholder received…